Alnylam welcomes you to Capella, the destination for updates on our progress in translating the science of RNAi toward innovative medicines.
July 23, 2014
We are hosting a series of online “RNAi Roundtables” during July and August, at which Alnylam scientists and key clinical collaborators will review recent progress from several “Alnylam 5×15” programs and discuss the related disease areas.
Next RNAi Roundtable:
ALN-HBV for the treatment of Hepatitis B Virus (HBV) Infection
Tuesday, July 29: 9:30 – 10:30 a.m. ET
- Laura Sepp-Lorenzino, Ph.D., Vice President, Entrepreneur-in-Residence
- Moderator: Laurence Reid, Ph.D., Senior Vice President and Chief Business Officer
- Guest Speaker: Graham Foster, Ph.D., FRCP, Professor of Hepatology at Queen Mary University of London
To register and access the webcast for this event, please click here.